Yale Liver Update 2025

Friday, December 12, 2025, 7:45 AM - 5:00 PM, The Anlyan Center (TAC), 300 Cedar Street, New Haven, CT

Yale Liver Update 2025 is an annual CME course designed to provide a comprehensive review of the latest advances in the science and practice of hepatology, including updated research and guidelines from key GI/hepatology specialty societies (AASLD, AGA, ACG), as well as summarize new evidence emerging from annual international liver meetings such as The Liver Meeting (AASLD) and International Liver Congress (EASL). Key educational content will be summarized to enhance clinical implementation in the context of clinicians within internal medicine, surgery, gastroenterology, and hepatology.

1. Describe optimal approaches to evidence-based treatment of hepatitis B and C infection with incorporation of new practice guidelines, including advances in antiviral therapy
2. Discuss recent developments in the diagnosis and treatment of acute and chronic diseases of the liver such as MASLD/MASH, PBC/PSC, autoimmune hepatitis, drug-induced liver injury, and alcohol-associated liver disease
3. Define optimal management approaches to improve outcomes in cirrhosis, portal hypertension, and liver transplantation
4. Review evidence and updated guidelines addressing the use of emerging diagnostic methods and therapies for hepatocellular carcinoma (HCC)

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Yale School of Medicine designates this enduring material for a maximum of 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

AMA PRA Category 1 Credits™ (8.00 hours), Non-Physician Attendance (8.00 hours)

Mitigation of Relevant Financial Relationships

Yale Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.